Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

[Prevention of physical disabilities due to leprosy in Brazil: a historic analysis].

Rosendo dos Santos A, Ignotti E. Ciencia & saude coletiva. 2020; 25 (10) : 3731-3744.
Download PDF
Publication

Histoid Leprosy: An Enemy Not Yet Eradicated.

Calvache N, Arias D, Delgado V. Actas dermo-sifiliograficas. 2020;
Download PDF
Publication

Onychomycosis caused by Arthrinium arundinis in leprosy patient: Case report

Vettorato R, Heidrich D, Eidt LM, et al. Elsevier BV. Medical Mycology Case Reports. 2020;
Download PDF
Publication

Epidemiological and spatial characterization of leprosy in Aracaju, Sergipe, Brazil

Silva CM, Araújo KCGMD, Reis FP, et al. Research, Society and Development. Research, Society and Development. 2020; 9 (10) : e2449108419.
Download PDF
Publication

Assistência do enfermeiro frente ao paciente com hanseníase: revisão narrativa

Mendes RNP, Lisboa MSA, Sena JFC, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Enfermagem. 2020;
Download PDF
Publication

Contexto clínico-epidemiológico dos casos de hanseníase notificados em Governador Valadares, Minas Gerais - Brasil, entre 2015 e 2019

Cardoso DM, Gomides TAR. Saúde (Santa Maria). 2020; 46 (2) : e44459.
Download PDF
Publication

Hanseníase: correlação entre o número de lesões hansênicas, nervos afetados e o diagnóstico precoce no estado de Minas Gerais

Pêgo AF, Eleutério D, Procópio JPM, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2020; 12 (9) : e2188.
Download PDF
Publication

Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports

Thangaraju P, Venkatesan S, Gurunthalingam M, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2020;
Download PDF
Publication

Detection of HLA-B 13:01 gene among Dapsone hypersensitivity patients of leprosy in Papua Ethnics group using sequence based typing and qPCR rapid detection

Krismawati H, Maladan Y, Rohman MF. AIP Publishing. THE 6TH INTERNATIONAL CONFERENCE ON BIOLOGICAL SCIENCE ICBS 2019: “Biodiversity as a Cornerstone for Embracing Future Humanity”. 2020;
Download PDF
Publication

Knowledge About Leprosy Among Health Care Workers In Balaka District, Southern Malawi

Mponda K, Anafi G, Laja ET, et al. Research Square. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 353
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD